Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,245,022
-
Share change
-
+6,527,862
-
Total reported value
-
$29,808,000
-
Price per share
-
$2.30
-
Number of holders
-
32
-
Value change
-
+$13,372,772
-
Number of buys
-
19
-
Number of sells
-
14
Institutional Holders of TRACON PHARMACEUTICALS INC - COM (TCON) as of Q1 2018
As of 31 Mar 2018,
TRACON PHARMACEUTICALS INC - COM (TCON) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,245,022 shares.
The largest 10 holders included
NEA Management Company, LLC, Puissance Capital Management LP, Linden Advisors LP, 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, JACOBS LEVY EQUITY MANAGEMENT, INC, Candriam Luxembourg S.C.A., Alyeska Investment Group, L.P., and RAYMOND JAMES & ASSOCIATES.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.